CRISPR Therapeutics CRSP FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CRISPR Therapeutics's FX effect on cash?
- CRISPR Therapeutics (CRSP) reported FX effect on cash of -$32K in Q1 2026.
- How has CRISPR Therapeutics's FX effect on cash changed year-over-year?
- CRISPR Therapeutics's FX effect on cash decreased by 178.0% year-over-year, from $41K to -$32K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.